Think of a computer chip and the materials that spring to mind will likely be silicon, copper and plastic. An ambitious startup from Australia is now throwing a novel ingredient into the mix: human brain cells.
Sanofi, the Paris-based pharmaceutical giant, has signed a research collaboration with Exscientia, which uses artificial intelligence to discover new drug candidates, that could be worth up to $5.2 billion for the Oxford, England–based company.
Small armed devices, often bought for a few hundred dollars online, are a big battlefield problem for the U.S. military, and developing a defense that is cost-effective against swarms of them is a conundrum. Laser and microwave weapons are among the new options.